USE OF INTERLEUKIN-21 FOR THE TREATMENT OF AUTOIMUNE DISEASES AND ALLOGRAFT REJECTION

摘要

The invention provides combination treatments with IL-21, an analogue, a derivative or active fragment thereof, an IL-21 mimetic or IL-21 polynucleotide.